More on DGX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $207.66 |
|
|||
| Open | $206.16 | ||||
| 52 Wk High | $86.85 | ||||
| 52 Wk Low | $59.66 | ||||
| Day High | $208.01 | ||||
| Day Low | $204.10 | ||||
| P/E | 38.95 | ||||
| EPS | $5.31 | ||||
| Volume | 691,873 | ||||
- Quest Diagnostics (DGX) PT Raised to $236 at Baird
- One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns
- Quest Diagnostics integrates cancer tests into Flatiron's OncoEMR platform
- Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
- Form 4 QUEST DIAGNOSTICS INC For: Jul 01 Filed by: WENTWORTH TIMOTHY C
- Quest Diagnostics wins New York approval for cancer MRD test
- Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
- Form 11-K QUEST DIAGNOSTICS INC For: Dec 31
- UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics
- Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Entities mentioned with DGX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
